MedTrace Logo

The Impact of Protein Intake on Protein Metabolism During Intensified Training

NCT02801344 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-03-29

No results posted yet for this study

Summary

Protein requirements in individuals who participate in endurance-based exercise training have been suggested to be greater than the current recommended dietary allowance (RDA).

Our recent study using the minimally invasive indicator amino acid oxidation (IAAO) technique have suggested that protein requirements in young men are at least 30% higher than the recommended protein intake.

The present study will investigate the impact of protein sufficiency on protein metabolism and performance during intensified training periods as a means to further our understanding of the nutritional requirements for the endurance athlete.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Normal

test drink which contains low amount of amino acids (0.14 g/kg/day)

DIETARY_SUPPLEMENT

Moderate

test drink which contains moderate amount of amino acids (0.40 g/kg/day)

DIETARY_SUPPLEMENT

High

test drink which contains high amount of amino acids (1.03 g/kg/day)

OTHER

Controlled-diet

the diet containing 0.8 g protein /kg/day

Sponsors & Collaborators

  • Ajinomoto Co., Inc.

    collaborator INDUSTRY

  • University of Toronto

    lead OTHER

Principal Investigators

  • Daniel Moore, Ph.D. · Faculty of Kinesiology and Physical Education, University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-09-30
Completion
2018-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02801344 on ClinicalTrials.gov